Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

June 15, 2026; Volume 23,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bai, Xiaoming

    1. Open Access
      Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives
      Yajing Liu, Yuwei Liu, Tingting Wu, Xiaoming Bai, Shuman Wang, Luyun Zhang, Zhiwen Fu and Chen Shi
      Cancer Biology & Medicine June 2026, 23 (6) 833-864; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0707
  2. Bao, Ensi

    1. Open Access
      HBx-mediated GPT2 suppression promotes liver cancer development by downregulating ADH1A
      Hongjuan You, Xing Wang, Ruyu Liu, Yuxin Wang, Huanyang Zhang, Lihong Ma, Ensi Bao, Yujie Zhong, Xiangye Liu, Delong Kong, Xiucheng Pan, Xiaocui Li, Suping Qin, Kuiyang Zheng, Chen Li, Renxian Tang and Fanyun Kong
      Cancer Biology & Medicine June 2026, 23 (6) 888-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0236
  3. Chen, Rui

    1. Open Access
      Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer
      Mingyue Zhao, Rui Chen and Ping Gao
      Cancer Biology & Medicine June 2026, 23 (6) 810-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0626
  4. Cui, Wei

    1. Open Access
      Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives
      Jing Yu, Maochen Li, Yuhan Zhu, Shengnan Wang, Yuzhao Jiang, Wei Cui and Lingying Wu
      Cancer Biology & Medicine June 2026, 23 (6) 788-795; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0102
  5. Cui, Yuzhen

    1. Open Access
      Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer
      Yuzhen Cui, Jingdong Xu, Junxu Wen, Jianfeng Peng, Jiangao Ren, Ailing Liu, Xiangjiao Meng, Zhaoqin Huang and Anwen Liu
      Cancer Biology & Medicine June 2026, 23 (6) 865-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0589
  6. Du, Sicheng

    1. Open Access
      Expansion of IL-2-independent tumor-infiltrating lymphocytes through a feeder-free process: a preclinical study for solid tumors
      Ying Zhang, Sicheng Du, Rongrui Liu, Chuanhua Zhao, Juan Li, Sisi Ye, Man Zhang, Xingming Ma, Zhou He, Wenjia Zhuang, Huajun Jin and Jianming Xu
      Cancer Biology & Medicine June 2026, 23 (6) 910-924; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0441
  7. Fu, Zhiwen

    1. Open Access
      Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives
      Yajing Liu, Yuwei Liu, Tingting Wu, Xiaoming Bai, Shuman Wang, Luyun Zhang, Zhiwen Fu and Chen Shi
      Cancer Biology & Medicine June 2026, 23 (6) 833-864; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0707
  8. Gao, Chuntao

    1. Open Access
      Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis
      Yang Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao and Jihui Hao
      Cancer Biology & Medicine June 2026, 23 (6) 946-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0848
  9. Gao, Ping

    1. Open Access
      Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer
      Mingyue Zhao, Rui Chen and Ping Gao
      Cancer Biology & Medicine June 2026, 23 (6) 810-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0626
  10. Hao, Jihui

    1. Open Access
      Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis
      Yang Liu, Dandan Wu, Xing Li, Xihao Zhang, Rentao Li, Yanmei Ou, Hao Wang, Tongguo Si, Rui Xia, Yong Xu, Huikai Li, Chuntao Gao and Jihui Hao
      Cancer Biology & Medicine June 2026, 23 (6) 946-950; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0848
« Previous (Pages : 1 2 3 4 5 6 ... 9) Next »
Back to top
Previous

In this issue

Cancer Biology & Medicine: 23 (6)
Cancer Biology & Medicine
Vol. 23, Issue 6
15 Jun 2026
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire